27 related articles for article (PubMed ID: 33112662)
1. Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.
Chen Y; Chen J; Shi Y; Ling X; Fang S; Zhong C; Liu F; Zhong W; Bi X; Dong Z; Lu J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38224097
[TBL] [Abstract][Full Text] [Related]
2. Nuclear peripheral chromatin-lamin B1 interaction is required for global integrity of chromatin architecture and dynamics in human cells.
Chang L; Li M; Shao S; Li C; Ai S; Xue B; Hou Y; Zhang Y; Li R; Fan X; He A; Li C; Sun Y
Protein Cell; 2022 Apr; 13(4):258-280. PubMed ID: 33155082
[TBL] [Abstract][Full Text] [Related]
3. Three CircRNAs Function as Potential Biomarkers for Colorectal Cancer.
Zhang J; Cai A; Zhao Y
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337836
[TBL] [Abstract][Full Text] [Related]
4. Silencing
Tang D; Luo H; Xie A; He Z; Zou B; Xu F; Zhang W; Xu X
Cancer Manag Res; 2021; 13():2633-2642. PubMed ID: 33776481
[TBL] [Abstract][Full Text] [Related]
5. LMNB1 targets FOXD1 to promote progression of prostate cancer.
Huang Y; Zhang L; Liu T; Liang E
Exp Ther Med; 2023 Nov; 26(5):513. PubMed ID: 37840569
[TBL] [Abstract][Full Text] [Related]
6. Multilevel view on chromatin architecture alterations in cancer.
Gridina M; Fishman V
Front Genet; 2022; 13():1059617. PubMed ID: 36468037
[TBL] [Abstract][Full Text] [Related]
7. LMNB1, a potential marker for early prostate cancer progression.
Hong JH; Liang ST; Wang AS; Yeh CM; Huang HP; Sun CD; Zhang ZH; Lu SY; Chao YH; Chen CH; Pu YS
Am J Cancer Res; 2022; 12(7):3390-3404. PubMed ID: 35968338
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Lamin B1 and the Corresponding Lamin B Receptor Leads to Changes in Heterochromatin State and Senescence Induction in Malignant Melanoma.
Lämmerhirt L; Kappelmann-Fenzl M; Fischer S; Pommer M; Zimmermann T; Kluge V; Matthies A; Kuphal S; Bosserhoff AK
Cells; 2022 Jul; 11(14):. PubMed ID: 35883595
[TBL] [Abstract][Full Text] [Related]
9. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma.
Yang Y; Gao L; Chen J; Xiao W; Liu R; Kan H
Bioengineered; 2022 Apr; 13(4):9211-9231. PubMed ID: 35436411
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of expression and prognosis for LMNB family genes in human sarcoma.
Wu G; Tian Q; Liu J; Zhou Q; Zou D; Chen Z; Wu T; Wang W; Xia H; Zhou J
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356902
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers.
Qin H; Lu Y; Du L; Shi J; Yin H; Jiang B; Chen W; Diao W; Ding M; Cao W; Qiu X; Zhao X; Guo H
Cancer Cell Int; 2022 Mar; 22(1):101. PubMed ID: 35241075
[TBL] [Abstract][Full Text] [Related]
12. Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients.
Luo F; Han J; Chen Y; Yang K; Zhang Z; Li J
Future Oncol; 2021 Feb; 17(6):663-673. PubMed ID: 33112662
[No Abstract] [Full Text] [Related]
13. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
14. ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.
Shimizu K; Matsumoto H; Hirata H; Ueno K; Samoto M; Mori J; Fujii N; Kawai Y; Inoue R; Yamamoto Y; Yano S; Shimabukuro T; Furutani-Seiki M; Matsuyama H
Oncol Rep; 2020 Dec; 44(6):2735-2745. PubMed ID: 33125156
[TBL] [Abstract][Full Text] [Related]
15. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
[TBL] [Abstract][Full Text] [Related]
16. The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.
Zhao SG; Evans JR; Kothari V; Sun G; Larm A; Mondine V; Schaeffer EM; Ross AE; Klein EA; Den RB; Dicker AP; Karnes RJ; Erho N; Nguyen PL; Davicioni E; Feng FY
Clin Cancer Res; 2016 Apr; 22(7):1777-86. PubMed ID: 26631616
[TBL] [Abstract][Full Text] [Related]
17. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
Bian Z; Huang X; Chen Y; Meng J; Feng X; Zhang M; Zhang L; Zhou J; Liang C
Int J Med Sci; 2021; 18(1):284-294. PubMed ID: 33390797
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
